The most common and well recognized genetic alteration in thyroid cancer is BRAF(V600E) mutation, which is present in up to 45% of thyroid malignancies and in up to 62% of radioactive iodine-resistant thyroid tumors. The gene discussed is BRAF; the disease is thyroid gland carcinoma.